NasdaqGM:GPCRPharmaceuticals
Assessing Structure Therapeutics (GPCR) Valuation After Recent Share Price Volatility
Structure Therapeutics (GPCR) has drawn investor attention after recent share price volatility, with the stock closing at US$48.59 and showing sizable moves over the past month and over the past three months.
See our latest analysis for Structure Therapeutics.
Those recent share price moves come after a sharp pullback. The 30 day share price return shows a 28.92% decline and the 90 day share price return shows a 25.18% decline, while the 1 year total shareholder return remains very large at...